Cytometry of chromatin bound Mcm6 and PCNA identifies two states in G1 that are separated functionally by the G1 restriction point.
BACKGROUND
Cytometric measurements of DNA content and chromatin-bound Mcm2 have demonstrated bimodal patterns of expression in G1. These patterns, the replication licensing function of Mcm proteins, and a correlation between Mcm loading and cell cycle commitment for cells re-entering the cell cycle, led us to test the idea that cells expressing a defined high level of chromatin-bound Mcm6 in G1 are committed--i.e., past the G1 restriction point. We developed a cell-based assay for tightly-bound PCNA (PCNA*) and Mcm6 (Mcm6*), DNA content, and a mitotic marker to clearly define G1, S, G2, and M phases of the cell cycle. hTERT-BJ1, hTERT-RPE-1, and Molt4 cells were extracted with Triton X-100 followed by methanol fixation, stained with antibodies and DAPI, then measured by cytometry.


RESULTS
Bivariate analysis of cytometric data demonstrated complex patterns with distinct clustering for all combinations of the 4 variables. In G1, cells clustered in two groups characterized by low and high Mcm6* expression. Serum starvation and release experiments showed that residence in the high group was in late G1, just prior to S phase. Kinetic experiments, employing serum withdrawal, and stathmokinetic analysis with aphidicolin, mimosine or nocodazole demonstrated that cells with high levels of Mcm6* cycled with the committed phases of the cell cycle (S, G2, and M).


CONCLUSIONS
A multivariate assay for Mcm6*, PCNA*, DNA content, and a mitotic marker provides analysis capable of estimating the fraction of pre and post-restriction point G1 cells and supports the idea that there are at least two states in G1 defined by levels of chromatin bound Mcm proteins.
Frisa
Phyllis S
PS
Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH 44106, USA.
Jacobberger
James W
JW
D000970:Antineoplastic Agents / Q000494:pharmacology; D016590:Aphidicolin / Q000494:pharmacology; D018797:Cell Cycle Proteins / Q000235:genetics / Q000378:metabolism*; D002454:Cell Differentiation / Q000187:drug effects; D045744:Cell Line, Tumor; D002469:Cell Separation; D002843:Chromatin / Q000378:metabolism*; D016895:Culture Media, Serum-Free; D004247:DNA / Q000032:analysis*; D005434:Flow Cytometry; D016193:G1 Phase / Q000187:drug effects / Q000235:genetics; D006801:Humans; D016399:Lymphoma, T-Cell / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D008898:Mimosine / Q000494:pharmacology; D064151:Minichromosome Maintenance Complex Component 6; D015739:Nocodazole / Q000494:pharmacology; D018809:Proliferating Cell Nuclear Antigen / Q000235:genetics / Q000378:metabolism*; D011485:Protein Binding / Q000187:drug effects
D000970:Antineoplastic Agents; D018797:Cell Cycle Proteins; D002843:Chromatin; D016895:Culture Media, Serum-Free; D018809:Proliferating Cell Nuclear Antigen; D016590:Aphidicolin; D008898:Mimosine; D004247:DNA; C103258:MCM6 protein, human; D064151:Minichromosome Maintenance Complex Component 6; D015739:Nocodazole
Biochim Biophys Acta. 1998 Jun 16;1398(2):113-36
9689912
Exp Cell Res. 1978 Oct 1;116(1):103-13
359338
Genes Dev. 2007 Dec 15;21(24):3331-41
18079179
Curr Opin Cell Biol. 1995 Dec;7(6):835-42
8608014
Cell. 2009 Mar 6;136(5):852-64
19269364
Cytometry A. 2005 Nov;68(1):10-8
16184610
Cancer Res. 1997 Mar 1;57(5):803-7
9041174
Mol Cell Biol. 2006 Feb;26(3):1051-62
16428457
Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):8956-61
18579778
Genome Res. 2009 Dec;19(12):2288-99
19767418
J Immunol Methods. 1988 Apr 22;109(1):49-59
2895795
Chromosome Res. 2010 Jan;18(1):63-77
19904620
Cancer Res. 1991 Sep 1;51(17):4570-4
1678682
Nature. 1970 Aug 15;227(5259):680-5
5432063
J Cell Biochem. 1995 Sep;59(1):42-52
8530535
J Cell Biol. 1999 Aug 23;146(4):709-22
10459007
J Theor Biol. 2004 Oct 21;230(4):563-79
15363676
Mol Cell. 2009 Jul 31;35(2):206-16
19647517
Curr Opin Cell Biol. 2006 Jun;18(3):231-9
16650748
Oncogene. 2005 Apr 18;24(17):2810-26
15838517
Adv Cancer Res. 1998;74:1-24
9561265
Cancer Res. 2000 Jul 15;60(14):3689-95
10919634
Mutat Res. 1999 Jan;436(1):1-9
9878675
Proc Natl Acad Sci U S A. 2008 Oct 14;105(41):15837-42
18838675
Cytometry A. 2005 Mar;64(1):34-42
15700280
J Cell Physiol. 2008 Apr;215(1):182-91
17960592
J Cell Biol. 2007 Aug 27;178(5):741-7
17724117
Philos Trans R Soc Lond B Biol Sci. 2004 Jan 29;359(1441):7-16
15065651
Curr Opin Cell Biol. 2006 Apr;18(2):130-6
16495042
Cytometry A. 2008 Jan;73(1):5-15
18061938
Trends Cell Biol. 2006 Jan;16(1):55-63
16337124
Acta Oncol. 1991;30(8):917-21
1685657
Cell Prolif. 1995 Feb;28(2):93-104
7893842
Curr Opin Cell Biol. 1997 Dec;9(6):768-72
9425340
PLoS One. 2009;4(5):e5462
19421323
Exp Cell Res. 1998 Oct 10;244(1):83-92
9770352
Oncogene. 2005 Apr 18;24(17):2827-43
15838518
Int J Biochem Cell Biol. 1997 Apr;29(4):559-73
9363633
Cytometry. 1996 Sep 1;25(1):1-13
8875049
Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350-4
388439
Exp Cell Res. 2005 May 1;305(2):383-91
15817163